Komori
Other Disclosures4882Perseus Proteomics Inc.Pharmaceuticals

Notice of Presentation at an IR Seminar for Individual Investors

The company announced plans to speak at an online IR briefing for individual investors on 1 July 2026. The President and Representative Director will explain the company's business overview and growth strategy and answer questions.

Worth reading
33Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Announced details

IR briefing for individual investors
Applicable field (uses covered by this announcement)

IR presentation for individual investors

Launch date1 July 2026 (Wednesday), from 19:00 (scheduled)
Relationship between the counterparty and the company
Perseus Proteomics Inc.4882
Relationship with the Company

The company will speak at an IR seminar organized by Wealth Advisor Co., Ltd. Capital and personnel relationships are not disclosed.

Counterpartyウエルスアドバイザー株式会社

Organizer of IR seminars for individual investors. Other details, including its location, representative, business activities, capital and year established, are not disclosed.

Location (as indicated in this announcement)

3rd Floor, A.i.Nihombashi EAST, 30-1 Nihombashihakozakicho, Chuo-ku, Tokyo

Offering price

Participation fee: Free

The company does not address Contract Value / Impact on Business Performance.

Announced details
ItemDetails
Names of Products / Services CoveredIR briefing for individual investors
Counterpartyウエルスアドバイザー株式会社
Counterparty overviewOrganizer of IR seminars for individual investors. Other details, including its location, representative, business activities, capital and year established, are not disclosed.
Relationship with the CompanyThe company will speak at an IR seminar organized by Wealth Advisor Co., Ltd. Capital and personnel relationships are not disclosed.
Offering priceParticipation fee: Free
Launch date1 July 2026 (Wednesday), from 19:00 (scheduled)
Applicable areaIR presentation for individual investors
Location3rd Floor, A.i.Nihombashi EAST, 30-1 Nihombashihakozakicho, Chuo-ku, Tokyo
Items this document does not state (10)
Contract ValueContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocation scaleQuantitative EffectsUsage historyImpact on Business PerformanceSource

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To enable a broad range of investors to view the seminar and deepen their understanding of the company.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of Presentation at an IR Seminar for Individual Investors | Perseus Proteomics Inc. (4882) timely disclosure | Komori